The excess insulin requirement in severe COVID‐19 compared to non‐COVID‐19 viral pneumonitis is related to the severity of respiratory failure and pre‐existing diabetes
Open Access
- 11 February 2021
- journal article
- research article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 4 (3) , e00228
Abstract
Introduction: Severe COVID‐19 has been anecdotally associated with high insulin requirements. It has been proposed that this may be driven by a direct diabetogenic effect of the virus that is unique to SARS‐CoV‐2, but evidence to support this is limited. To explore this, we compared insulin requirements in patients with severe COVID‐19 and non‐COVID‐19 viral pneumonitis.Methods: This is a retrospective cohort study of patients with severe COVID‐19 admitted to our intensive care unit between March and June 2020. A historical control cohort of non‐COVID‐19 viral pneumonitis patients was identified from routinely collected audit data.Results: Insulin requirements were similar in patients with COVID‐19 and non‐COVID‐19 viral pneumonitis after adjustment for pre‐existing diabetes and severity of respiratory failure.Conclusions: In this single‐centre study, we could not find evidence of a unique diabetogenic effect of COVID‐19. We suggest that high insulin requirements in this disease relate to its propensity to cause severe respiratory failure in patients with pre‐existing metabolic disease.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deteriorationDiabetes Research and Clinical Practice, 2020
- New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.Diabetes Care, 2020
- Management of diabetes in patients with COVID-19The Lancet Diabetes & Endocrinology, 2020
- Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in GermanyJAMA, 2020
- COVID‐19 and diabetes: Insulin requirements parallel illness severity in critically unwell patientsClinical Endocrinology, 2020
- Practical recommendations for the management of diabetes in patients with COVID-19The Lancet Diabetes & Endocrinology, 2020
- Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literatureDiabetologia, 2020
- Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United StatesJournal of Diabetes Science and Technology, 2020
- Study protocol and statistical analysis plan for the Liberal Glucose Control in Critically Ill Patients with Pre-existing Type 2 Diabetes (LUCID) trialCritical Care and Resuscitation, 2020
- Stress hyperglycaemiaThe Lancet, 2009